Global and Japan Bioactive Protein and Peptides Market Report & Forecast 2022-2028
Description
Market Analysis and Insights: Global and Japan Bioactive Protein and Peptides Market
This report focuses on global and Japan Bioactive Protein and Peptides market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Bioactive Protein and Peptides market size is estimated to be worth US$ 1,695.84 million in 2022 and is forecast to a readjusted size of US$ 2,533.48 million by 2028 with a CAGR of 6.92% during the review period. Fully considering the economic change by this health crisis, Plant Source accounting for 55.64% of the Bioactive Protein and Peptides global market in 2021, is projected to value US$ 1,480.85 million by 2028, growing at a revised 7.66% CAGR in the post-COVID-19 period. While Dietary Supplements was the leading segment, accounting for over 42.79% percent market share in 2021, and altered to an 7.55% CAGR throughout this forecast period.
In Japan the Bioactive Protein and Peptides market size is expected to grow from US$ 52.35 million in 2021 to US$ 87.17 million by 2028, at a CAGR of 7.75% during the forecast period.
Global Bioactive Protein and Peptides Scope and Market Size
Bioactive Protein and Peptides market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Bioactive Protein and Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
For Japan market, this report focuses on the Bioactive Protein and Peptides market size by players, by Type, and by Application, for the period 2017-2028. The key players include the global and local players which play important roles in Japan.
Segment by Type
Plant Source
Animal Source
Segment by Application
Dietary Supplements
Functional Food
Personal Care
Animal Nutrition
Other
By Company
Gelita
Kerry Group
Vital Proteins
Rousselot
BRF Ingredients
Bunge Ltd
Ingredia Nutritional
Gelatines Weishardt
PanTheryx
Hubei Rui Biological Technology
Seagarden
Shandong Hengxin Biotech
Baotou Dongbao Bio-Tech
Wuhan Jiushengtang Biotech
Morinaga Milk
Collagile
Nuritas
SmartPEP
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
Korea
Australia
South Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
GCC Countries
Turkey
South Africa
Egypt
This report focuses on global and Japan Bioactive Protein and Peptides market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Bioactive Protein and Peptides market size is estimated to be worth US$ 1,695.84 million in 2022 and is forecast to a readjusted size of US$ 2,533.48 million by 2028 with a CAGR of 6.92% during the review period. Fully considering the economic change by this health crisis, Plant Source accounting for 55.64% of the Bioactive Protein and Peptides global market in 2021, is projected to value US$ 1,480.85 million by 2028, growing at a revised 7.66% CAGR in the post-COVID-19 period. While Dietary Supplements was the leading segment, accounting for over 42.79% percent market share in 2021, and altered to an 7.55% CAGR throughout this forecast period.
In Japan the Bioactive Protein and Peptides market size is expected to grow from US$ 52.35 million in 2021 to US$ 87.17 million by 2028, at a CAGR of 7.75% during the forecast period.
Global Bioactive Protein and Peptides Scope and Market Size
Bioactive Protein and Peptides market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Bioactive Protein and Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
For Japan market, this report focuses on the Bioactive Protein and Peptides market size by players, by Type, and by Application, for the period 2017-2028. The key players include the global and local players which play important roles in Japan.
Segment by Type
Plant Source
Animal Source
Segment by Application
Dietary Supplements
Functional Food
Personal Care
Animal Nutrition
Other
By Company
Gelita
Kerry Group
Vital Proteins
Rousselot
BRF Ingredients
Bunge Ltd
Ingredia Nutritional
Gelatines Weishardt
PanTheryx
Hubei Rui Biological Technology
Seagarden
Shandong Hengxin Biotech
Baotou Dongbao Bio-Tech
Wuhan Jiushengtang Biotech
Morinaga Milk
Collagile
Nuritas
SmartPEP
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
Korea
Australia
South Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
GCC Countries
Turkey
South Africa
Egypt
Table of Contents
116 Pages
- 1 Study Coverage
- 1.1 Bioactive Protein and Peptides Product Introduction
- 1.2 Global Bioactive Protein and Peptides Outlook, 2017 VS 2022 VS 2028
- 1.2.1 Global Bioactive Protein and Peptides Market Size for the Year 2017-2028
- 1.2.2 Japan Bioactive Protein and Peptides Market Size for the Year 2017-2028
- 1.3 Bioactive Protein and Peptides Market Size, Japan VS Global, 2017 VS 2022 VS 2028
- 1.3.1 The Market Share of Japan Bioactive Protein and Peptides in Global, 2017 VS 2022 VS 2028
- 1.3.2 The Growth Rate of Bioactive Protein and Peptides Market Size, Japan VS Global, 2017 VS 2022 VS 2028
- 1.4 Bioactive Protein and Peptides Market Dynamics
- 1.4.1 Bioactive Protein and Peptides Industry Trends
- 1.4.2 Bioactive Protein and Peptides Market Drivers
- 1.4.3 Bioactive Protein and Peptides Market Challenges
- 1.5 Study Objectives
- 1.6 Years Considered
- 2 Bioactive Protein and Peptides by Type
- 2.1 Bioactive Protein and Peptides Market Segment by Type
- 2.1.1 Plant Source
- 2.1.2 Animal Source
- 2.2 Global Bioactive Protein and Peptides Market Size by Type (2017, 2022 & 2028)
- 2.3 Global Bioactive Protein and Peptides Market Size by Type (2017-2028)
- 2.4 Japan Bioactive Protein and Peptides Market Size by Type (2017, 2022 & 2028)
- 2.5 Japan Bioactive Protein and Peptides Market Size by Type (2017-2028)
- 3 Bioactive Protein and Peptides by Application
- 3.1 Bioactive Protein and Peptides Market Segment by Application
- 3.1.1 Dietary Supplements
- 3.1.2 Functional Food
- 3.1.3 Personal Care
- 3.1.4 Animal Nutrition
- 3.2 Global Bioactive Protein and Peptides Market Size, by Application (2017, 2022 & 2028)
- 3.3 Global Bioactive Protein and Peptides Market Size by Application (2017-2028)
- 3.4 Japan Bioactive Protein and Peptides Market Size by Application (2017, 2022 & 2028)
- 3.5 Japan Bioactive Protein and Peptides Market Size by Application (2017-2028)
- 4 Global Bioactive Protein and Peptides Competitor Landscape by Company
- 4.1 Global Bioactive Protein and Peptides Market Size by Company
- 4.1.1 Top Global Bioactive Protein and Peptides Companies Ranked by Revenue (2021)
- 4.1.2 Global Bioactive Protein and Peptides Revenue by Player (2017-2022)
- 4.2 Global Bioactive Protein and Peptides Concentration Ratio (CR)
- 4.2.1 Bioactive Protein and Peptides Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Companies of Bioactive Protein and Peptides in 2021
- 4.2.3 Global Bioactive Protein and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Bioactive Protein and Peptides Headquarters, Product Type
- 4.3.1 Global Bioactive Protein and Peptides Headquarters and Area Served
- 4.3.2 Global Bioactive Protein and Peptides Companies Product Type
- 4.3.3 Date of International Companies Establishment
- 4.4 Companies Mergers & Acquisitions, Expansion Plans
- 4.5 Japan Bioactive Protein and Peptides Market Size by Company
- 4.5.1 Top Bioactive Protein and Peptides Players in Japan, Ranked by Revenue (2021)
- 4.5.2 Japan Bioactive Protein and Peptides Revenue by Players (2020, 2021 & 2022)
- 5 Global Bioactive Protein and Peptides Market Size by Region
- 5.1 Global Bioactive Protein and Peptides Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Bioactive Protein and Peptides Market Size by Region (2017-2028)
- 5.2.1 Global Bioactive Protein and Peptides Market Size by Region: 2017-2022
- 5.2.2 Global Bioactive Protein and Peptides Market Size by Region: 2023-2028
- 6 Segment in Regional Level & Country Level
- 6.1 North America
- 6.1.1 North America Bioactive Protein and Peptides Market Size YoY Growth 2017-2028
- 6.1.2 North America Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Bioactive Protein and Peptides Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Bioactive Protein and Peptides Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 Australia
- 6.2.7 Southeast Asia
- 6.2.8 India
- 6.3 Europe
- 6.3.1 Europe Bioactive Protein and Peptides Market Size YoY Growth 2017-2028
- 6.3.2 Europe Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Bioactive Protein and Peptides Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Brazil
- 6.4.4 Mexico
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Bioactive Protein and Peptides Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 GCC Countries
- 6.5.4 Turkey
- 6.5.5 Egypt
- 6.5.6 South Africa
- 7 Key Players Profiles
- 7.1 Gelita
- 7.1.1 Gelita Company Details
- 7.1.2 Gelita Business Overview
- 7.1.3 Gelita Bioactive Protein and Peptides Introduction
- 7.1.4 Gelita Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.2 Kerry Group
- 7.2.1 Kerry Group Company Details
- 7.2.2 Kerry Group Business Overview
- 7.2.3 Kerry Group Bioactive Protein and Peptides Introduction
- 7.2.4 Kerry Group Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.3 Vital Proteins
- 7.3.1 Vital Proteins Company Details
- 7.3.2 Vital Proteins Business Overview
- 7.3.3 Vital Proteins Bioactive Protein and Peptides Introduction
- 7.3.4 Vital Proteins Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.4 Rousselot
- 7.4.1 Rousselot Company Details
- 7.4.2 Rousselot Business Overview
- 7.4.3 Rousselot Bioactive Protein and Peptides Introduction
- 7.4.4 Rousselot Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.5 BRF Ingredients
- 7.5.1 BRF Ingredients Company Details
- 7.5.2 BRF Ingredients Business Overview
- 7.5.3 BRF Ingredients Bioactive Protein and Peptides Introduction
- 7.5.4 BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.6 Bunge Ltd
- 7.6.1 Bunge Ltd Company Details
- 7.6.2 Bunge Ltd Business Overview
- 7.6.3 Bunge Ltd Bioactive Protein and Peptides Introduction
- 7.6.4 Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.7 Ingredia Nutritional
- 7.7.1 Ingredia Nutritional Company Details
- 7.7.2 Ingredia Nutritional Business Overview
- 7.7.3 Ingredia Nutritional Bioactive Protein and Peptides Introduction
- 7.7.4 Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.8 Gelatines Weishardt
- 7.8.1 Gelatines Weishardt Company Details
- 7.8.2 Gelatines Weishardt Business Overview
- 7.8.3 Gelatines Weishardt Bioactive Protein and Peptides Introduction
- 7.8.4 Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.9 PanTheryx
- 7.9.1 PanTheryx Company Details
- 7.9.2 PanTheryx Business Overview
- 7.9.3 PanTheryx Bioactive Protein and Peptides Introduction
- 7.9.4 PanTheryx Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.10 Hubei Reborn Biotech
- 7.10.1 Hubei Reborn Biotech Company Details
- 7.10.2 Hubei Reborn Biotech Business Overview
- 7.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Introduction
- 7.10.4 Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.11 Seagarden
- 7.11.1 Seagarden Company Details
- 7.11.2 Seagarden Business Overview
- 7.11.3 Seagarden Bioactive Protein and Peptides Introduction
- 7.11.4 Seagarden Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.12 Shandong Hengxin Biotech
- 7.12.1 Shandong Hengxin Biotech Company Details
- 7.12.2 Shandong Hengxin Biotech Business Overview
- 7.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Introduction
- 7.12.4 Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.13 Baotou Dongbao Bio-Tech
- 7.13.1 Baotou Dongbao Bio-Tech Company Details
- 7.13.2 Baotou Dongbao Bio-Tech Business Overview
- 7.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Introduction
- 7.13.4 Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.14 Wuhan Jiushengtang Biotech
- 7.14.1 Wuhan Jiushengtang Biotech Company Details
- 7.14.2 Wuhan Jiushengtang Biotech Business Overview
- 7.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Introduction
- 7.14.4 Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.15 Morinaga Milk
- 7.15.1 Morinaga Milk Company Details
- 7.15.2 Morinaga Milk Business Overview
- 7.15.3 Morinaga Milk Bioactive Protein and Peptides Introduction
- 7.15.4 Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.16 Collagile
- 7.16.1 Collagile Company Details
- 7.16.2 Collagile Business Overview
- 7.16.3 Collagile Bioactive Protein and Peptides Introduction
- 7.16.4 Collagile Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.17 Nuritas
- 7.17.1 Nuritas Company Details
- 7.17.2 Nuritas Business Overview
- 7.17.3 Nuritas Bioactive Protein and Peptides Introduction
- 7.17.4 Nuritas Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 7.17.5 Nuritas Recent Development
- 7.18 SmartPEP
- 7.18.1 SmartPEP Company Details
- 7.18.2 SmartPEP Business Overview
- 7.18.3 SmartPEP Bioactive Protein and Peptides Introduction
- 7.18.4 SmartPEP Revenue in Bioactive Protein and Peptides Business (2017-2022)
- 8 Research Findings and Conclusion
- 9 Appendix
- 9.1 Research Methodology
- 9.1.1 Methodology/Research Approach
- 9.1.2 Data Source
- 9.2 Disclaimer
- 9.3 Author Details
- List of Tables
- Table 1. Bioactive Protein and Peptides Market Size, Japan VS Global, CAGR (2017 VS 2022 VS 2028)
- Table 2. Bioactive Protein and Peptides Market Trends
- Table 3. Bioactive Protein and Peptides Market Drivers
- Table 4. Bioactive Protein and Peptides Market Challenges
- Table 5. Global Bioactive Protein and Peptides Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
- Table 6. Japan Bioactive Protein and Peptides Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
- Table 7. Global Bioactive Protein and Peptides Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
- Table 8. Japan Bioactive Protein and Peptides Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
- Table 9. Top Bioactive Protein and Peptides Companies in Global Market, Ranking by Revenue (2021)
- Table 10. Global Bioactive Protein and Peptides Revenue by Player, (US$ Million), 2017-2022
- Table 11. Global Bioactive Protein and Peptides Revenue Share by Player, 2017-2022
- Table 12. Global Bioactive Protein and Peptides Companies Market Concentration Ratio (CR5)
- Table 13. Global Bioactive Protein and Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2021)
- Table 14. Top Players of Bioactive Protein and Peptides in Global Market, Headquarters and Area Served
- Table 15. Global Bioactive Protein and Peptides Companies Product Type
- Table 16. Date of International Companies Establishment
- Table 17. Companies Mergers & Acquisitions, Expansion Plans
- Table 18. Top Bioactive Protein and Peptides Players in Japan Market, Ranking by Revenue (2021)
- Table 19. Japan Bioactive Protein and Peptides Revenue by Players, (US$ Million), 2020, 2021 & 2022
- Table 20. Japan Bioactive Protein and Peptides Revenue Share by Players, 2020, 2021 & 2022
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
